Management of Fragments During Ureteroscopy

NCT ID: NCT00637650

Last Updated: 2009-02-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2007-06-30

Study Completion Date

2008-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to study the outcome of patients after ureteroscopy in which all fragments remaining after holmium laser lithotripsy were retrieved compared to those where small, insignificant fragments were left for spontaneous passage.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Urinary Stones

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

B

Experimental group: patients in whom "stone dust" was left for spontaneous elimination

Group Type EXPERIMENTAL

Ureteroscopy, Holmium laser lithotripsy, no intent to retrieve any remaining fragment

Intervention Type PROCEDURE

A

Control group: Patients in whom all fragments resulting from laser lithotripsy of ureteral stones were actively retrieved

Group Type OTHER

Ureteroscopy, Holmium Laser lithotripsy and active retrieval of fragments

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ureteroscopy, Holmium Laser lithotripsy and active retrieval of fragments

Intervention Type PROCEDURE

Ureteroscopy, Holmium laser lithotripsy, no intent to retrieve any remaining fragment

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with ureteral stones suitable for endoscopic treatment

Exclusion Criteria

* presence of ipsilateral kidney stones
* known ureteral stricture
* previous placement of ureteral stent
* use of drugs with known activity on smooth ureteral muscle
* unwillingness or impossibility to return for follow-up
Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

The Chaim Sheba Medical Center

OTHER

Sponsor Role lead

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Chaim Sheba Medical Center

Tel Litwinsky, Ramat Gan, Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

4638

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Lithotripsy for the Treatment of Gallstones
NCT00042549 TERMINATED PHASE4
HoYAG vs TFL in miniPCNL With ClearPetra
NCT07087977 NOT_YET_RECRUITING NA